Developing antisense oligonucleotide (ASO) therapies for rare genetic disorders.
About
Quiver Bioscience is an AI-driven therapeutics company focused on accelerating the discovery of empirically grounded treatments for neurological diseases. They leverage a platform integrating scalable biology, advanced technology, and AI models to identify novel therapeutic targets and candidate molecules, aiming to deliver safer, more effective CNS drugs faster and at lower cost. Their approach utilizes patient-derived stem-cell models and all-optical electrophysiology to gain insights into complex brain biology and assess drug efficacy and toxicity.
Tags
Performance
Company Timeline
No timeline data for this period
Discussion (0)
Join the discussion
No comments yet. Be the first to share your thoughts!
Frequently Asked Questions
What does Quiver Bioscience do?
Quiver Bioscience is an AI-driven therapeutics company focused on accelerating the discovery of empirically grounded treatments for neurological diseases. They leverage a platform integrating scalable biology, advanced technology, and AI models to identify novel therapeutic targets and candidate molecules, aiming to deliver safer, more effective CNS drugs faster and at lower cost. Their approach utilizes patient-derived stem-cell models and all-optical electrophysiology to gain insights into com…
Where is Quiver Bioscience headquartered?
Quiver Bioscience is headquartered in Cambridge, Massachusetts, USA.
When was Quiver Bioscience founded?
Quiver Bioscience was founded in 2021.
What industry does Quiver Bioscience operate in?
Quiver Bioscience operates in Biotechnology, Pharmaceuticals, Rare Diseases, Genetics.
Similar Startups